查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941783

寡核苷酸合成市場規模、佔有率和趨勢分析報告：按產品/服務、應用、最終用途、地區和細分市場預測（2026-2033 年）

Oligonucleotide Synthesis Market Size, Share & Trends Analysis Report By Product & Service, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

寡核苷酸合成市場概述

全球寡核苷酸合成市場預計到 2025 年將價值 36.4 億美元，預計到 2033 年將達到 108.6 億美元。

預計從 2026 年到 2033 年，該市場將以 14.95% 的複合年成長率成長。這一成長是由寡核苷酸在治療和診斷中的應用日益廣泛、基因組學研究投資不斷增加以及可擴展合成技術的進步所推動的，而製藥和生物技術公司的強勁需求也支撐了市場的擴張。

核酸治療方法的發展

推動寡核苷酸合成市場成長的關鍵因素是核酸治療方法的快速發展。反義寡核苷酸、siRNA、mRNA療法和基因編輯技術等治療方法需要高度精確的寡核苷酸，而這又需要更精確、更全面的合成技術。此外，針對遺傳疾病、腫瘤和感染疾病的監管核准不斷增加以及強大的臨床研發管線也促進了市場成長。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場動態
  • 產業分析工具
    • 波特五力分析
    • PESTEL 分析

第4章 產品與服務業務分析

  • 寡核苷酸合成市場：產品與服務波動分析
  • 寡核苷酸
    • 2021-2033年全球寡核苷酸市場
    • 產品類型
            少於65 nt
              65歲以下市場，2021-2033年
  • 設備/合成設備
    • 2021-2033年全球儀器/合成設備市場
  • 試劑
    • 全球試劑市場，2021-2033年
  • 服務
    • 2021-2033年全球服務市場
    • DNA
    • RNA

第5章：按應用程式進行業務分析

  • 寡核苷酸合成市場：按應用領域分類的差異分析
  • PCR引子
    • 全球PCR引子市場，2021-2033年
  • PCR檢測與試劑盒
    • 全球PCR檢測與試劑盒市場，2021-2033年
  • 定序
    • 全球定序市場，2021-2033年
  • DNA微陣列
    • 全球DNA微陣列市場，2021-2033年
  • 螢光原位雜合反應（FISH）
    • 2021-2033年全球螢光原位雜合反應（FISH）市場
  • 反義寡核苷酸
    • 2021-2033年全球反義寡核苷酸市場
  • 其他用途
    • 全球其他地區應用市場，2021-2033年

第6章 依最終用途進行業務分析

  • 寡核苷酸合成市場：終端用途差異分析
  • 學術研究機構
    • 2021-2033年全球學術研究市場
  • 診斷檢查室
    • 2021-2033年全球診斷檢查室市場
  • 製藥和生物技術公司
    • 2021-2033年全球醫藥與生技市場

第7章：區域商業分析

  • 2025年及2033年各地區寡核苷酸合成市場佔有率
  • 北美洲
    • 2021-2033年北美寡核苷酸合成市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2021-2033年歐洲寡核苷酸合成市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2021-2033年亞太地區寡核苷酸合成市場
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 2021-2033年拉丁美洲寡核苷酸合成市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2021-2033年中東及非洲寡核苷酸合成市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 公司分類
  • 策略規劃
  • 企業市場占有率分析（2025）
  • 公司簡介/列表
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher
    • Revvity Discovery Limited
    • Agilent Technologies, Inc.
    • Bio-Synthesis, Inc.
    • Kaneka Eurogentec SA
    • LGC Biosearch Technologies
    • Biolegio
    • Twist Bioscience
Product Code: GVR-2-68038-593-9

Oligonucleotide Synthesis Market Summary

The global oligonucleotide synthesis market size was estimated at USD 3.64 billion in 2025 and is projected to reach USD 10.86 billion by 2033, growing at a CAGR of 14.95% from 2026 to 2033. Growth is driven by increasing use of oligonucleotides in therapeutics and diagnostics, rising genomics research investments, and technological advances in scalable synthesis, with strong demand from pharmaceutical and biotechnology companies supporting market expansion.

Growth of Nucleic Acid-Based Therapies

The primary factor responsible for the growth of the oligonucleotide synthesis market is the rapidly growing nucleic acid-based therapies. High-precision oligonucleotides are needed for therapeutic measures like antisense oligonucleotides, siRNA, mRNA therapies, and gene-editing technologies, which, in turn, require more accurate and more extensive synthesis. Moreover, the increasing number of regulatory approvals and the ongoing strong clinical pipeline against genetic, oncological, and infectious diseases are also contributing to the growth of the market.

Global Oligonucleotide Synthesis Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global oligonucleotide synthesis market on the basis of product & service, application, end-use, and region:

  • Product & Service Scope Outlook (Revenue, USD Million, 2021 - 2033)
  • Oligonucleotides
    • Product type
    • DNA
    • Technology
    • Column-based
    • Array-based
    • RNA
    • Technology
    • Column-based
    • Array-based
    • Type
    • Short RNA Oligos (<65 nt)
    • Long RNA Oligos (>65 nt)
    • CRISPR (sgRNA)
  • Equipment/Synthesizer
  • Reagents
  • Services
    • DNA
    • Custom Oligo Synthesis Services
    • 25 nmol
    • 50 nmol
    • 200 nmol
    • 1000 nmol
    • 10000 nmol
    • Modification Services
    • Purification Services
    • RNA
    • Custom Oligo Synthesis Services
    • 25 nmol
    • 100 nmol
    • 1000 nmol
    • 10000 nmol
    • Modification Services
    • Purification Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • PCR Primers
  • PCR Assays and Panels
  • Sequencing
  • DNA Microarrays
  • Fluorescence In Situ Hybridization (FISH)
  • Antisense Oligonucleotides
  • Other Applications
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic Research Institutes
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Regional Outlook (Revenue, USD Million, 2021- 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product & Service Segment
      • 1.1.1.2. Application Segment
      • 1.1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objective
    • 1.4.1. Objective 1
    • 1.4.2. Objective2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growth of nucleic acid-based therapies
      • 3.2.1.2. Rising use in molecular diagnostics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with genomics research
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Product & Service Business Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Oligonucleotide Synthesis Market: Product & Service Movement Analysis
  • 4.3. Oligonucleotides
    • 4.3.1. Global oligonucleotides market, 2021 - 2033 (USD million)
    • 4.3.2. Product type
      • 4.3.2.1. Global product type oligonucleotides market, 2021 - 2033 (USD million)
      • 4.3.2.2. DNA
        • 4.3.2.2.1. Global DNA market, 2021 - 2033 (USD million)
        • 4.3.2.2.2. Technology
          • 4.3.2.2.2.1. Global technology oligonucleotides market, 2021 - 2033 (USD million)
          • 4.3.2.2.2.2. Column-based
            • 4.3.2.2.2.2.1. Global column-based market, 2021 - 2033 (USD million)
          • 4.3.2.2.2.3. Array-based
            • 4.3.2.2.2.3.1. Global array-based market, 2021 - 2033 (USD million)
      • 4.3.2.3. RNA
        • 4.3.2.3.1. Global RNA market, 2021 - 2033 (USD million)
        • 4.3.2.3.2. Technology
          • 4.3.2.3.2.1. Global technology oligonucleotides market, 2021 - 2033 (USD million)
          • 4.3.2.3.2.2. Column-based
            • 4.3.2.3.2.2.1. Global column-based market, 2021 - 2033 (USD million)
          • 4.3.2.3.2.3. Array-based
            • 4.3.2.3.2.3.1. Global array-based market, 2021 - 2033 (USD million)
        • 4.3.2.3.3. Type
          • 4.3.2.3.3.1. Global type oligonucleotides market, 2021 - 2033 (USD million)
          • 4.3.2.3.3.2. Short RNA Oligos (<65 nt)
            • 4.3.2.3.3.2.1. Global short RNA oligos (<65 nt) market, 2021 - 2033 (USD million)
          • 4.3.2.3.3.3. Long RNA Oligos (>65 nt)
            • 4.3.2.3.3.3.1. Global long RNA oligos (>65 nt) market, 2021 - 2033 (USD million)
          • 4.3.2.3.3.4. CRISPR (sgRNA)
            • 4.3.2.3.3.4.1. Global CRISPR (sgRNA) market, 2021 - 2033 (USD million)
  • 4.4. Equipment/Synthesizer
    • 4.4.1. Global equipment/synthesizer market, 2021 - 2033 (USD million)
  • 4.5. Reagents
    • 4.5.1. Global reagents market, 2021 - 2033 (USD million)
  • 4.6. Services
    • 4.6.1. Global Services market, 2021 - 2033 (USD million)
    • 4.6.2. DNA
      • 4.6.2.1. Global DNA market, 2021 - 2033 (USD million) market, 2021 - 2033 (USD million)
      • 4.6.2.2. Custom Oligo Synthesis Services
        • 4.6.2.2.1. Global custom oligo synthesis services market, 2021 - 2033 (USD million)
        • 4.6.2.2.2. 25 nmol
          • 4.6.2.2.2.1. Global 25 nmol market, 2021 - 2033 (USD million)
        • 4.6.2.2.3. 50 nmol
          • 4.6.2.2.3.1. Global 50 nmol market, 2021 - 2033 (USD million)
        • 4.6.2.2.4. 200 nmol
          • 4.6.2.2.4.1. Global 200 nmol market, 2021 - 2033 (USD million)
        • 4.6.2.2.5. 1000 nmol
          • 4.6.2.2.5.1. Global 1000 nmol market, 2021 - 2033 (USD million)
        • 4.6.2.2.6. 10000 nmol
          • 4.6.2.2.6.1. Global 10000 nmol market, 2021 - 2033 (USD million)
      • 4.6.2.3. Modification Services
        • 4.6.2.3.1. Global modification services market, 2021 - 2033 (USD million)
      • 4.6.2.4. Purification Services
        • 4.6.2.4.1. Global purification services market, 2021 - 2033 (USD million)
    • 4.6.3. RNA
      • 4.6.3.1. Global RNA market, 2021 - 2033 (USD million)
      • 4.6.3.2. Global DNA market, 2021 - 2033 (USD million) market, 2021 - 2033 (USD million)
      • 4.6.3.3. Custom Oligo Synthesis Services
        • 4.6.3.3.1. Global custom oligo synthesis services market, 2021 - 2033 (USD million)
        • 4.6.3.3.2. 25 nmol
          • 4.6.3.3.2.1. Global 25 nmol market, 2021 - 2033 (USD million)
        • 4.6.3.3.3. 50 nmol
          • 4.6.3.3.3.1. Global 50 nmol market, 2021 - 2033 (USD million)
        • 4.6.3.3.4. 200 nmol
          • 4.6.3.3.4.1. Global 200 nmol market, 2021 - 2033 (USD million)
        • 4.6.3.3.5. 1000 nmol
          • 4.6.3.3.5.1. Global 1000 nmol market, 2021 - 2033 (USD million)
        • 4.6.3.3.6. 10000 nmol
          • 4.6.3.3.6.1. Global 10000 nmol market, 2021 - 2033 (USD million)
      • 4.6.3.4. Modification Services
        • 4.6.3.4.1. Global modification services market, 2021 - 2033 (USD million)
      • 4.6.3.5. Purification Services
        • 4.6.3.5.1. Global purification services market, 2021 - 2033 (USD million)

Chapter 5. Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Oligonucleotide Synthesis Market: Application Movement Analysis
  • 5.3. PCR Primers
    • 5.3.1. Global PCR primers market, 2021 - 2033 (USD million)
  • 5.4. PCR Assays and Panels
    • 5.4.1. Global PCR assays and panels market, 2021 - 2033 (USD million)
  • 5.5. Sequencing
    • 5.5.1. Global sequencing market, 2021 - 2033 (USD million)
  • 5.6. DNA Microarrays
    • 5.6.1. Global DNA microarrays market, 2021 - 2033 (USD million)
  • 5.7. Fluorescence In Situ Hybridization (FISH)
    • 5.7.1. Global Fluorescence In Situ Hybridization (FISH) market, 2021 - 2033 (USD million)
  • 5.8. Antisense Oligonucleotides
    • 5.8.1. Global antisense oligonucleotides market, 2021 - 2033 (USD million)
  • 5.9. Other Applications
    • 5.9.1. Global other applications market, 2021 - 2033 (USD million)

Chapter 6. End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Oligonucleotide Synthesis Market: End Use Movement Analysis
  • 6.3. Academic Research Institutes
    • 6.3.1. Global academic research institutes market, 2021 - 2033 (USD million)
  • 6.4. Diagnostic Laboratories
    • 6.4.1. Global diagnostic laboratories market, 2021 - 2033 (USD million)
  • 6.5. Pharmaceutical and Biotechnology Companies
    • 6.5.1. Global pharmaceutical and biotechnology companies market, 2021 - 2033 (USD million)

Chapter 7. Regional Business Analysis

  • 7.1. Oligonucleotide Synthesis Market Share By Region, 2025 & 2033
  • 7.2. North America
    • 7.2.1. North America Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Competitive Scenario
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Mexico Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. UK Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Germany Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Denmark Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Australia Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Thailand Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. South Korea Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Argentina Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. South Africa Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Saudi Arabia Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. UAE Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Kuwait Oligonucleotide Synthesis Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Danaher
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Revvity Discovery Limited
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Agilent Technologies, Inc.
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Bio-Synthesis, Inc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Product Benchmarking
      • 8.4.6.3. Strategic Initiatives
    • 8.4.7. Kaneka Eurogentec S.A.
      • 8.4.7.1. Overview
      • 8.4.7.2. Product Benchmarking
      • 8.4.7.3. Strategic Initiatives
    • 8.4.8. LGC Biosearch Technologies
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Biolegio
      • 8.4.9.1. Overview
      • 8.4.9.2. Product Benchmarking
      • 8.4.9.3. Strategic Initiatives
    • 8.4.10. Twist Bioscience
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 Global oligonucleotide synthesis market, by region, 2021 - 2033 (USD Million)
  • Table 2 Global oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 3 Global oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 4 Global oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 5 North America oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 6 North America oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 7 U.S. oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 8 U.S. oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 9 U.S. oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 10 Canada oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 11 Canada oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 12 Canada oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Mexico oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 14 Mexico oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 15 Mexico oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Europe oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 17 Europe oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 18 Europe oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 19 UK oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 20 UK oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 21 UK oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 22 Germany oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 23 Germany oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 24 Germany oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 25 France oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 26 France oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 27 France oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Italy oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 29 Italy oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 30 Italy oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 31 Spain oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 32 Spain oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 33 Spain oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 34 Denmark oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 35 Denmark oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 36 Denmark oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 37 Sweden oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 38 Sweden oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 39 Sweden oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 40 Norway oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 41 Norway oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 42 Norway oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific oligonucleotide synthesis market, by application, 2021 - 2033 (USD Millon)
  • Table 45 Asia Pacific oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Millon)
  • Table 46 Japan oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 47 Japan oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 48 Japan oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 49 China oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 50 China oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 51 China oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 52 India oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 53 India oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 54 India oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 55 Australia oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 56 Australia oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 57 Australia oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 58 South Korea oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 59 South Korea oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 60 South Korea oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Thailand oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 62 Thailand oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 63 Thailand oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 64 Latin America oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 65 Latin America oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 66 Latin America oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 67 Brazil oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 68 Brazil oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 69 Brazil oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Argentina oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 71 Argentina oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 72 Argentina oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Middle East & Africa oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 74 Middle East & Africa oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 75 Middle East & Africa oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 76 South Africa oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 77 South Africa oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 78 South Africa oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 79 Saudi Arabia oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 80 Saudi Arabia oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 81 Saudi Arabia oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 82 UAE oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 83 UAE oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 84 UAE oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)
  • Table 85 Kuwait oligonucleotide synthesis market, by product & services, 2021 - 2033 (USD Million)
  • Table 86 Kuwait oligonucleotide synthesis market, by application, 2021 - 2033 (USD Million)
  • Table 87 Kuwait oligonucleotide synthesis market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Oligonucleotide synthesis market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Market trends & outlook
  • Fig. 16 PESTEL analysis
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 Oligonucleotide synthesis market: Product & Services outlook & key takeaways
  • Fig. 19 Oligonucleotide synthesis market: Product & Services movement analysis
  • Fig. 20 Oligonucleotides market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 DNA market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Column-based market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Array-based market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 RNA market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Column-based market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Array-based market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Short RNA Oligos (<65 nt) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Long RNA Oligos (>65 nt) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 CRISPR (sgRNA) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Equipment/Synthesizer market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Reagents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 DNA market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Custom Oligo Synthesis Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 25 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 50 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 200 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 1000 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 10000 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Modification Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Purification Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 RNA market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Oligo Synthesis Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 25 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 50 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 200 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 1000 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 10000 nmol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Modification Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Purification Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Oligonucleotide synthesis market: Application outlook key takeaways
  • Fig. 52 Oligonucleotide synthesis market: Application movement analysis
  • Fig. 53 PCR Primers oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 PCR Assays and Panels oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Sequencing oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 DNA Microarrays oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Fluorescence In Situ Hybridization (FISH) oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Antisense Oligonucleotides oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Other Applications oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Oligonucleotide synthesis market: End use outlook key takeaways
  • Fig. 61 Oligonucleotide synthesis market: End use movement analysis
  • Fig. 62 Academic Research Institutes oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Diagnostic Laboratories oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Pharmaceutical - Biotechnology Companies oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Regional outlook
  • Fig. 66 Regional marketplace: Key takeaways
  • Fig. 67 North America oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 U.S. oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Canada oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Mexico oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Europe oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Germany oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 UK oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 France oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Italy oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Spain oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Denmark oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Sweden oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Norway oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Asia Pacific oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Japan oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 China oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 India oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Australia oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Thailand oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 South Korea oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 104 Latin America oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 Brazil oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Argentina oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 109 MEA oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 South Africa oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 Saudi Arabia oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 114 Key country dynamics
  • Fig. 115 UAE oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 116 Key country dynamics
  • Fig. 117 Kuwait oligonucleotide synthesis market estimates and forecasts, 2021 - 2033 (USD Million)